2023
DOI: 10.1038/s41380-023-02135-7
|View full text |Cite|
|
Sign up to set email alerts
|

Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer’s Disease male mice

Abstract: Alzheimer’s Disease (AD) is a prevalent neurodegenerative disease characterized by tau hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents directed at mitigating tau aggregation and clearing Aβ1-42, and delivery of growth factor genes (BDNF, FGF2), have ameliorated cognitive deficits, but these approaches did not prevent or stop AD progression. Here we report that viral-(AAV) delivery of Neurotrophic Factor-α1/Carboxypeptidase E (NF-α1/CPE) gene in hippocampus at an early age… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 62 publications
0
0
0
Order By: Relevance
“…The amyloid-beta 1-42 (Aβ1-42) peptide is a primary component of the amyloid plaques found in the brains of individuals with AD. It is believed to play a critical role in the neuropathology of AD by initiating a cascade of events that leads to neuronal dysfunction and death[ 3 ]. Memory loss and cognitive decline are caused by the buildup of Aβ plaques, neurofibrillary tangles, and synaptic and neuronal loss in individuals with AD[ 4 - 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…The amyloid-beta 1-42 (Aβ1-42) peptide is a primary component of the amyloid plaques found in the brains of individuals with AD. It is believed to play a critical role in the neuropathology of AD by initiating a cascade of events that leads to neuronal dysfunction and death[ 3 ]. Memory loss and cognitive decline are caused by the buildup of Aβ plaques, neurofibrillary tangles, and synaptic and neuronal loss in individuals with AD[ 4 - 6 ].…”
Section: Introductionmentioning
confidence: 99%